Refractory proctocolitis in the exclusively breast-fed infants

Marina Atanaskovic-Markovic1

  • 1University Children's Hospital, Medical Faculty University of Belgrade, Serbia. marinaa@eunet.rs.

Insights

Cow's milk protein allergy can cause rectal bleeding in exclusively breast-fed infants. Maternal avoidance of cow's milk protein typically resolves symptoms within 96 hours, with most infants tolerating cow's milk by age one.

Area of Science:

  • Pediatrics
  • Allergy and Immunology
  • Gastroenterology

Background:

  • Cow's milk protein allergy is a common concern in infants.
  • Allergic proctocolitis presents as rectal bleeding in exclusively breast-fed infants (1-6 months).
  • Cow's milk protein can transfer through breast milk, triggering allergic reactions.

Purpose of the Study:

  • To guide pediatricians and primary care physicians in diagnosing cow's milk protein allergy.
  • To provide management strategies for exclusively breast-fed infants with this allergy.
  • To clarify the link between maternal diet and infant allergic proctocolitis.

Main Methods:

  • Clinical feature assessment for diagnosis.
  • Dietetic therapy (maternal cow's milk avoidance) as a diagnostic and therapeutic tool.
  • Monitoring infant response to dietary changes.

Main Results:

  • Rectal bleeding in infants is often linked to cow's milk protein exposure via breast milk.
  • Maternal avoidance of cow's milk protein leads to symptom resolution within 72-96 hours.
  • The majority of affected infants can tolerate cow's milk by their first birthday.

Conclusions:

  • Cow's milk protein allergy is a manageable cause of rectal bleeding in breast-fed infants.
  • Diagnosis relies on clinical presentation and response to dietary intervention.
  • Early identification and management improve infant outcomes and support continued breastfeeding.

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
61
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
42
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
917
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.4K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
900
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K